Plasma apelin and vascular endothelial growth factor levels in preterm infants: relationship to neonatal respiratory distress syndrome

References

• Jaberi E, Roksana M. A study on preterm births during 2013–2015, Shiraz, Iran. J Obstet Gynaecol. 2018; 38(1):22–26.
   PubMedGoogle Scholar
• Donda K, Vijayakanthi N, Dapaah-Siakwan F, et al. Trends in epidemiology and outcomes of respiratory distress syndrome in the United States. Pediatr Pulmonol. 2019; 54(4):405–414.
   PubMed Web of Science ®Google Scholar
• Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012; 11(11):CD001456.
   PubMed Web of Science ®Google Scholar
• Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome - 2016 Update. Neonatology. 2017;111(2):107–125.
   PubMed Web of Science ®Google Scholar
• Carlton DP, Albertine KH, Cho SC, et al. Role of neutrophils in lung vascular injury and edema after premature birth in lambs. J Appl Physiol (1985). 1997; 83(4):1307–1317.
   PubMed Web of Science ®Google Scholar
• Turunen R, Nupponen I, Siitonen S, et al. Onset of mechanical ventilation is associated with rapid activation of circulating phagocytes in preterm infants. Pediatrics. 2006;117(2):448–454.
   PubMed Web of Science ®Google Scholar
• Bertrand C, Pradère JP, Geoffre N, et al. Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism. Endocrine. 2018;60(1):112–121.
   PubMed Web of Science ®Google Scholar
• Cheng J, Luo X, Huang Z, et al. Apelin/APJ system: a potential therapeutic target for endothelial dysfunction-related diseases. J Cell Physiol. 2019;234(8):12149–12160.
   PubMed Web of Science ®Google Scholar
• Fan XF, Xue F, Zhang YQ, et al. The Apelin-APJ axis is an endogenous counter injury mechanism in experimental acute lung injury. Chest. 2015;147(4):969–978.
   PubMed Web of Science ®Google Scholar
• Vafaee F. Using multi-objective optimization to identify dynamical network biomarkers as early-warning signals of complex diseases. Sci Rep. 2016;6:22023.
   PubMed Web of Science ®Google Scholar
• Koyama S, Sato E, Tsukadaira A, et al. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur Respir J. 2002; 20(6):1449–1456.
   PubMed Web of Science ®Google Scholar
• Boussat S, Eddahibi S, Coste A, et al. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2000;279(2):L371–8.
   PubMed Web of Science ®Google Scholar
• Lassus P, Ristimäki A, Ylikorkala O, et al. Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med. 1999;159(5):1429–1433.
   PubMed Web of Science ®Google Scholar
• Abadie Y, Bregeon F, Papazian L, et al. Decreased VEGF concentration in lung tissue and vascular injury during ARDS. Eur Respir J. 2005;25(1):139–146.
   PubMed Web of Science ®Google Scholar
• Arthur R. The neonatal chest X-ray. Paediatr Respir Rev. 2001; 2(4):311–323.
   PubMedGoogle Scholar
• Than A, Cheng Y, Foh LC, et al. Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol. 2012;362(1-2):227–241.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen S, Zeng M, et al. Apelin-13 administration protects against LPS-Induced acute lung injury by inhibiting NF-κB pathway and NLRP3 inflammasome activation. Cell Physiol Biochem. 2018;49(5):1918–1932.
   PubMedGoogle Scholar
• He Q, Wang Y, Yang H, et al. Apelin-36 protects against lipopolysaccharide-induced acute lung injury by inhibiting the ASK1/MAPK signaling pathway. Mol Med Rep. 2020;23(1):1–1.
   PubMed Web of Science ®Google Scholar
• Plouët J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. Embo J. 1989; 8(12):3801–3806.
   PubMed Web of Science ®Google Scholar
• Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983; 219(4587):983–985.
   PubMed Web of Science ®Google Scholar
• Compernolle V, Brusselmans K, Acker T, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med. 2002;8(7):702–710.
   PubMed Web of Science ®Google Scholar
• Lassus P, Turanlahti M, Heikkilä P, et al. Pulmonary vascular endothelial growth factor and flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1981–1987.
   PubMed Web of Science ®Google Scholar
• Tsao PN, Wei SC, Chou HC, et al. Vascular endothelial growth factor in preterm infants with respiratory distress syndrome. Pediatr Pulmonol. 2005;39(5):461–465.
   PubMed Web of Science ®Google Scholar
• Been JV, Zoer B, Kloosterboer N, et al. Pulmonary vascular endothelial growth factor expression and disaturated phospholipid content in a chicken model of hypoxia-induced fetal growth restriction. Neonatology. 2010;97(3):183–189.
   PubMed Web of Science ®Google Scholar
• Yang WC, Chen CY, Chou HC, et al. Angiogenic factors in cord blood of preterm infants predicts subsequently developing bronchopulmonary dysplasia. Pediatr Neonatol. 2015;56(6):382–385.
   PubMed Web of Science ®Google Scholar
• Mariduena J, Ramagopal M, Hiatt M, et al. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants. J Matern Fetal Neonatal Med. 2022;35:(8):1517–1516.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang YR, Lu Q, et al. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab. Retina (Philadelphia, Pa). 2013;33(3):613–620.
   PubMed Web of Science ®Google Scholar
• Feng J, Zhou Y, Zhang X, et al. Vascular endothelial growth factor and apelin in plasma of patients with retinopathy of prematurity. Acta Ophthalmol. 2017;95(6):e514–e515.
   PubMed Web of Science ®Google Scholar
• Huang C, Dai C, Gong K, et al. Apelin-13 protects neurovascular unit against ischemic injuries through the effects of vascular endothelial growth factor. Neuropeptides. 2016;60:67–74.
   PubMed Web of Science ®Google Scholar
• Uribesalgo I, Hoffmann D, Zhang Y, et al. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy. EMBO Mol Med. 2019;11(8):e9266.
   PubMed Web of Science ®Google Scholar
• Kim SM, Park YJ, Chung SH, et al. Early prophylactic versus late selective use of surfactant for respiratory distress syndrome in very preterm infants: a collaborative study of 53 multi-center trials in Korea. J Korean Med Sci. 2014;29(8):1126–1131.
   PubMed Web of Science ®Google Scholar
• Verder H, Agertoft L, Albertsen P, et al. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study. Ugeskr Laeger. 1992;154(31):2136–2139.
   PubMedGoogle Scholar
• McGillick EV, Orgeig S, Morrison JL. Structural and molecular regulation of lung maturation by intratracheal vascular endothelial growth factor administration in the normally grown and placentally restricted fetus. J Physiol. 2016;594(5):1399–1420.
   PubMed Web of Science ®Google Scholar